Modulation of ABCA1 by an LXR agonist reduces ?-amyloid levels and improves outcome after traumatic brain injury.

Modulation of ABCA1 by an LXR agonist reduces ?-amyloid levels and improves outcome after traumatic brain injury. J Neurotrauma. 2011 Feb; 28(2):225-36.

View in: PubMed

subject areas

Amyloid beta-Peptides
Animals
ATP Binding Cassette Transporter 1
ATP-Binding Cassette Transporters
Brain Injuries
Disease Models, Animal
Hydrocarbons, Fluorinated
Liver X Receptors
Mice
Mice, Inbred C57BL
Orphan Nuclear Receptors
Recovery of Function
Sulfonamides
Time Factors
Treatment Outcome

authors with profiles

Ana Pocivavsek